Moreover, the increase in CD8+ T cell numbers in head and neck tumors after TGF-β inhibition was attenuated upon blockade of IFNAR, suggesting that macrophage-derived type I IFN augmented T cell-mediated anti-tumor immunity. Here, IFNAR1 is linked to neoplasm.